Skip to main content

Table 1 Frequency of drugs administered to JDM patients in EU and LA centers

From: Differences in therapeutic approach to juvenile dermatomyositis between Europe and Latin America

  Oral/iv steroids Pulse iv steroids MTX CyA Iv Ig AM AZA Oral CPM Pulse iv CPM
EU (N = 246) 97.6 50 50.8 35 17.1 26 13.4 5.3 8.5
LA (N = 236) 99.6 33.2 61.4 15.7 17.4 39 5.9 2.1 4.2
  1. MTX: methotrexate; CyA: cyclosporine A; AM: antimalarials; AZA: azathioprine; CPM: cyclophosphamide